Abdullah Al-Abcha(@AbdullahAlabcha) 's Twitter Profileg
Abdullah Al-Abcha

@AbdullahAlabcha

Cardiology fellow @MayoCVFellows🫀| @MSU_Medicine & @UJ_MED Alum.🇯🇴 | #SoMe Editor #JACCINT @JACCJournals | Mesopotamian🇮🇶

ID:1245024302354829319

linkhttps://pubmed.ncbi.nlm.nih.gov/?term=Al-Abcha+A&sort=date calendar_today31-03-2020 16:25:07

982 Tweets

1,9K Followers

803 Following

Umair Khalid(@Umair2017) 's Twitter Profile Photo

✨Cardiac Sarcoidosis (CS): AHA just dropped an enlightening Scientific Statement! 📜

below for all u need to know about CS: Epidemiology, Diagnosis & Management 💥

🧵1/12

Circulation AHA Science BCM Cardiology Aga Khan University

✨Cardiac Sarcoidosis (CS): AHA just dropped an enlightening Scientific Statement! 📜 #Tweetorial below for all u need to know about CS: Epidemiology, Diagnosis & Management 💥 🧵1/12 #CardioTwitter #Cardiology #ACCFIT @CircAHA @AHAScience @BCMHeart @AKUGlobal #MedTwitter
account_circle
Mohamad Alkhouli(@adnanalkhouli) 's Twitter Profile Photo

A heartfelt farewell to 3 star researchers whose curiosity, energy & teamwork have left an indelible mark Mayo Clinic CV

Shih-Sheng Chang to direct Cath lab at CMUH 🇹🇼
Gerardo Lo Russo starting an academic cardiologist position at U of Milan 🇮🇹
Agata Sularz joining Mayo Clinic Internal Medicine Residency Rochester🇺🇸

A heartfelt farewell to 3 star researchers whose curiosity, energy & teamwork have left an indelible mark @MayoClinicCV @chssheng to direct Cath lab at CMUH 🇹🇼 @GerardoLoRusso starting an academic cardiologist position at U of Milan 🇮🇹 @aga_sularz joining @MayoMN_IMRES🇺🇸
account_circle
Mayra Guerrero, MD(@MayraGuerreroMD) 's Twitter Profile Photo

We evaluated 820 patients treated with TS MViR using the Sapien 3/Ultra/RESILIA THVs between Aug 2015 and Dec 2022 who were enrolled in the STS/ACC TVT Registry. We found a significant reduction in MR and sustained improvement in symptoms at 1 year. Mean mitral gradients were

account_circle
JACC Journals(@JACCJournals) 's Twitter Profile Photo

This analysis of the registry investigated the 1-year outcomes of using the system 👇

⬆️Survival ⬇️ hospitalization ⬆️ 👌🏻 bit.ly/3Jf2uqk

This #JACCINT analysis of the #MiCLASP registry investigated the 1-year outcomes of #TEER using the #PASCAL system 👇 ⬆️Survival ⬇️ #HeartFailure hospitalization ⬆️#QoL 👌🏻 bit.ly/3Jf2uqk
account_circle
JACC Journals(@JACCJournals) 's Twitter Profile Photo

What are the contemporary outcomes of transcatheter mitral valve-in-ring? Check out this analysis of the registry 👉 bit.ly/49B4nbu

Significant reduction with ⬆️ , however ⬆️ gradient and ⬆️ reintervention

Mayra Guerrero, MD

What are the contemporary outcomes of transcatheter mitral valve-in-ring? Check out this #JACCINT analysis of the #TVT registry 👉 bit.ly/49B4nbu Significant #MR reduction with ⬆️ #QoL, however ⬆️ gradient and ⬆️ reintervention #MViR #vhdMR @MayraGuerreroMD
account_circle
Abdullah Al-Abcha(@AbdullahAlabcha) 's Twitter Profile Photo

🚨Check out our analysis of 1,420 patients with mild mitral annular calcification 👇🏽

✳️The presence of mild MAC ⬆️ risk of ☠️
✳️~15% developed significant MVD at 4.7 years follow up
✳️At follow up, more prevalent

onlinejase.com/article/S0894-…

🚨Check out our analysis of 1,420 patients with mild mitral annular calcification #MAC👇🏽 ✳️The presence of mild MAC ⬆️ risk of #mortality☠️ ✳️~15% developed significant MVD at 4.7 years follow up ✳️At follow up, #MR more prevalent #MS onlinejase.com/article/S0894-… #CardioTwitter
account_circle
Garrett Welle M.D.(@GarrettWelleMD) 's Twitter Profile Photo

🔥Hot off the press:

🫀 New Approaches to Assessment
and Management of Tricuspid
Regurgitation Before Intervention: State-of-the-Art Review out now in JACC Journals intervention

📝- jacc.org/doi/pdf/10.101…

🔥Hot off the press: 🫀 New Approaches to Assessment and Management of Tricuspid Regurgitation Before Intervention: State-of-the-Art Review out now in @JACCJournals intervention 📝- jacc.org/doi/pdf/10.101…
account_circle
Umair Khalid(@Umair2017) 's Twitter Profile Photo

SMART trial results just presented at

SEV vs BEV for small annuli

✅SEV non-inferior to BEV in clinical endpoint @ 1 year
✅ SEV superior to BEV in valve function endpoint

♦️will the long term outcomes be better with SEV? 🤔

SMART trial results just presented at #ACC24 #LBCT SEV vs BEV #TAVR for small annuli ✅SEV non-inferior to BEV in clinical endpoint @ 1 year ✅ SEV superior to BEV in valve function endpoint ♦️will the long term outcomes be better with SEV? 🤔 #CardioTwitter #ACCFIT
account_circle
Davide Capodanno(@DFCapodanno) 's Twitter Profile Photo

After 10 years to complete it, the DanGer-SHOCK trial showed that the routine use of a microaxial flow pump with standard care in the treatment of patients with STEMI-related cardiogenic shock led to a lower risk of death from any cause at 180 days than standard care alone.

The

After 10 years to complete it, the DanGer-SHOCK trial showed that the routine use of a microaxial flow pump with standard care in the treatment of patients with STEMI-related cardiogenic shock led to a lower risk of death from any cause at 180 days than standard care alone. The
account_circle
Evangelos K. Oikonomou(@ekoikonomou) 's Twitter Profile Photo

Outstanding ideas, work and presentations by the ⭐️ Mayo Clinic CV fellows David Harmon MD and Abdullah Al-Abcha - honored to share the stage with them this morning as part of the Heart Tank

account_circle
Francis Alenghat(@alenghat) 's Twitter Profile Photo

Sunday AM, $10K to the winner of Heart Tank For the Cardiovascular Investigator: The Susan Smyth Memorial Tournament of Champions
, on the Engage Stage 9:15 AM, moderated by Eric J Velazquez & Nicole Lohr, MD, PhD , contestants and discussants below:

Sunday AM, $10K to the winner of Heart Tank For the Cardiovascular Investigator: The Susan Smyth Memorial Tournament of Champions #ACC24 #ACCAcademic, on the Engage Stage 9:15 AM, moderated by @ericjvelazquez & @NicoleLohrMD , contestants and discussants below:
account_circle